Hypoparathyroidism News is a digital platform providing daily updates on research, science and advice news for Hypoparathyroidism patients and caregivers.
(4)
14/08/2024
The U.S. Food and Drug Administration (FDA) has approved Yorvipath (palopegteriparatide) as a hypoparathyroidism treatment for adults. https://buff.ly/4cmdAG1
05/08/2024
Long-lasting hypoparathyroidism following surgery in the U.S. is linked to more hospitalizations and higher healthcare-related medical costs. https://buff.ly/46ygVk6
01/07/2024
Fahr syndrome, kidney stones, cataracts were seen most frequently in chronic hypoparathyroidism patients who'd had the disease a long time. https://buff.ly/4cmWj09
03/06/2024
Treatment with TransCon PTH for up to two years leads to sustained improvements in kidney function of adults with chronic hypoparathyroidism, data show. https://buff.ly/45fogEI
17/05/2024
Regulators have approved TransCon PTH for hypoparathyroidism in the European Union and Great Britain, where it is available as Yorvipath. https://buff.ly/4dIt4pU
06/05/2024
US regulators gave fast track designation to eneboparatide, an experimental hypoparathyroidism treatment now in an enrolling Phase 3 trial. https://buff.ly/44u7Is0
01/04/2024
Slightly under 20% of the patients who had their thyroid gland removed had hypoparathyroidism a year after surgery, a 20-year study shows. https://buff.ly/49kVwuH
04/03/2024
About one in five adults with hypoparathyroidism had impaired kidney function in a study based on real-life data. https://buff.ly/431qLcC
05/02/2024
The injection treatment previously known as TransCon PTH is approved in the Europe Union for adults, and under regulatory review in UK, US. https://buff.ly/3Ut2ZUE
16/01/2024
Help connect rare disease communities for more effective advocacy and support for all. Take our survey for a chance to win 1 of 10 $50 Amazon eGift cards: https://bit.ly/3vJk568
08/01/2024
People with a high body fat have a lower risk of developing hypoparathyroidism following total thyroid gland removal surgery, a study reports. https://buff.ly/41On9tE
Be the first to know and let us send you an email when Hypoparathyroidism News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.